DAFTAR PUSTAKA

1. Setiabudi D. Evalution of Clinical Pattern and Pathogenesis of Dengue

Haemorrhagic Fever. Dalam : Garna H, Nataprawira HMD, Alam A, penyunting.
Proceedings Book 13th National Congress of Child Health. KONIKA XIII.
Bandung, July 4-7, 2005. h. 329
2. Hadinegoro SRS. Pitfalls & Pearls dalam Diagnosis dan Tata Laksana Demam
Berdarah Dengue. Dalam : Trihono PP, Syarif DR, Amir I, Kurniati N, penyunting.
Current Management of Pediatrics Problems. Pendidikan Kedokteran
Berkelanjutan Ilmu Kesehatan Anak XLVI. Jakarta 5-6 September 2006.h. 63
3. Dengue fever [Internet]. MedicineNet. [cited 2018 Jan 12]. Available from:
http://www.medicinenet.com/script/main/art.asp?articlekey=6626
4. Miller N. Recent Progress in dengue vaccine research and development.
CurrOpinion Mol Ther. 2010;12:31–8.
5. Murrel S, et al. Review of dengue virus and the development of a Vaccine.
Biotechnol Adv. 2011;29:239–47.
6. Monika S, et al. Advances in the development of vaccines for dengue fever.
Dovepress. 2012;2:1–14.
7. Louisa M, et al. Revised Guidelines on Fluid management of dengue fever and
dengue Hemorrhagic Fever. PPS. 2012;(4):1–22.
8. WHO | Impact of Dengue [Internet]. WHO. [cited 2018 Jan 13]. Available from:
http://www.who.int/csr/disease/dengue/impact/en/
9. Martina BEE, Koraka P, Osterhaus ADME. Dengue Virus Pathogenesis: an
Integrated View. Clin Microbiol Rev. 2009 Oct 1;22(4):564–81.
10. Sellahewa KH. Pathogenesis of Dengue Haemorrhagic Fever and Its Impact on
Case Management. Int Sch Res Not. 2012 Oct 21;2013:e571646.
11. Halstead S. Dengue. Lancet. 2007;1644–52.
12. Wills B, et al. Comparison of three fluid solutions for resuscitation in dengue shock
syndrome. N Engl J Med. 2005;353:877–89.
13. SEARO | Comprehensive Guidelines for Prevention and Control of Dengue and
Dengue Haemorrhagic Fever [Internet]. SEARO. [cited 2014 Dec 16]. Available
from:
http://www.searo.who.int/entity/vector_borne_tropical_diseases/documents/SEA
ROTPS60/en/

36
14. Gurugama P, Garg P, Perera J, Wijewickrama A, Seneviratne SL. DENGUE
VIRAL INFECTIONS. Indian J Dermatol. 2010;55(1):68–78.
15. Whitehorn J, Chau NVV, Truong NT, Tai LTH, Van Hao N, Hien TT, et al.
Lovastatin for adult patients with dengue: protocol for a randomised controlled trial.
Trials. 2012 Oct 31;13:203.
16. Da Costa VG, Marques-Silva AC, Floriano VG, Moreli ML. Safety,
immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: a meta-
analysis of randomized trials. Vaccine. 2014 Sep 3;32(39):4885–92.
17. Bhatt S et al. The global distribution and burden of dengue. Nature. 2013;496:504-
507.
18. Yauch LE. Shresta S. Dengue Virus Vaccine Development. Advances in Virus
Research. 2014;88:315-373
19. Pierson TC, Diamond MS.Vaccine Development as a Means to Control Dengue
Virus Pathogenesis: Do We Know Enough?. Annual Review of Virology. 2014;1:
375-398.

37